Edwards Lifesciences Corp — insider transactions
5 transactions on record · EW · CIK 1099800
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
5
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$0
Sold, 3m
$493.1K
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
$245.1K
2026-07-27
Director share, 12m
60.0%
of transactions where role is stated
Current run
5 sells
consecutive same-direction transactions
Net 3m flow
-$493.1K
purchases minus sales
Total on record
5
Transactions
5 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-28 | 2026-08-28 | 0 | Bruls Annette | CVP, EMEACLA | Open market sale | 2,644 | $89.98 | $237.9K | filing |
| 2026-07-27 | 2026-07-27 | 0 | Zovighian Bernard J | Director, CEO | Gift | 320 | $0.00 | — | filing |
| 2026-07-27 | 2026-07-27 | 0 | Zovighian Bernard J | Director, CEO | Open market sale | 2,921 | $83.93 | $245.1K | filing |
| 2026-07-27 | 2026-07-27 | 0 | Zovighian Bernard J | Director, CEO | Gift | 320 | $0.00 | — | filing |
| 2026-07-13 | 2026-07-11 | 2 | Bruls Annette | CVP, EMEACLA | Shares withheld for tax | 109 | $92.21 | $10.1K | filing |